A variety of systemic inflammatory rheumatic diseases associate with an increased risk of
atherosclerotic events and premature cardiovascular (CV) disease. Although this recognition …

There is intense interest in mechanisms whereby low-grade inflammation could interact with
conventional and novel vascular risk factors to promote the atheromatous lesion. Patients …

Cardiovascular disease is a major health care problem and the most common cause of
death among individuals from developed nations. Our understanding of atherosclerosis has …

Patients with rheumatic disorders have an increased risk of cardiovascular disease (CVD).
This excess co-morbidity is not fully explained by traditional risk factors. Disease severity is a …

Similarities between the inflammatory pathways in atherosclerosis and rheumatoid arthritis
(RA) are striking. Chronic systemic inflammation in RA patients leads to cardiovascular (CV) …

The inflammatory pathogenesis of atherosclerosis is now well-established, owing to in vitro
and in vivo studies and the application of high sensitivity assays for C-reactive protein (CRP) …

Rheumatoid arthritis (RA) has long been associated with increased cardiovascular risk, but
despite substantial improvements in disease management, mortality remains high …

The pathogenesis of cardiovascular disease in rheumatoid arthritis is complex and involves
several intermediate factors, including dyslipidemia, elevations in serum homocysteine …

Risk of cardiovascular (CV) disease is increased among RA patients. High inflammatory
burden associated with RA appears to be a key driver of the increased cardiovascular risk …

Rheumatoid arthritis (RA) associates with increased cardiovascular mortality. This appears
to be predominantly due to ischaemic causes, such as myocardial infarction and congestive …